Please provide your email address to receive an email when new articles are posted on . WASHINGTON — In the first randomized trial of a therapy for treatment of patients with angina and nonobstructive ...
WASHINGTON, DC—Patients with angina but no obstructive coronary artery disease (ANOCA) see no reduction in coronary vasomotor dysfunction when taking the calcium channel blocker diltiazem, data from ...
In a randomized trial of patients with angina and no obstructive coronary artery disease (ANOCA), 6 weeks of treatment with diltiazem did not improve coronary vasomotor dysfunction — apart from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback